GENEVA, Sept. 18 -- IMMORTA BIO, INC. filed a patent application (US2026/018036) for “SYSTEMIC REJUVENATION USING EXOSOMES DERIVED FROM AUTOLOGOUS DEDIFFERENTIATED REGENERATIVE CELLS”. With publication no. WO/2026/188115, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 35/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....